Summary
Recently our group demonstrated that it is possible to differentiate nonsteroidal anti-inflammatory drugs (NSAIDs) as analgesic agents in the management of acute musculoskeletal pain. In this paper, we extend this work to investigate the notion that the analgesic and anti-inflammatory potency of an NSAID is not simply related through a common mechanism, namely the inhibition of peripheral prostaglandin (PG) synthesis. Following an extensive survey of the published literature for a series of acidic NSAIDs, we could not find any significant correlation between potency as an analgesic agent or as an anti-inflammatory agent and analgesic efficacy in clinical practice. Importantly, we now demonstrate for the first time that it is potency as an analgesic agent relative to potency as an anti-inflammatory agent that covaries with clinical efficacy. We discuss the possibility that, for a given NSAID, the magnitude of this dissociation between analgesic and anti-inflammatory potencies may reflect the net effect of a complex interaction between peripheral and central sites of action, and between diverse mechanisms of action that are independent of an inhibition of PG synthesis. Our results provide a clinically meaningful differentiation of NSAIDs through the use of in vivo data.
Similar content being viewed by others
References
Vane JR. Inhibition of prostaglandin-synthesis as a mechanism of action of aspirin-like drugs. Nature (New Biol) 1971; 231: 232–5
Flower RJ. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 1974; 26: 33–67
Ferreira SH, Nakamura M. -Prostaglandin hyperalgesia: A cAMP/Ca2+ dependent process. Prostaglandins 1979; 18: 179–90
Urquhart E. Central analgesic activity of nonsteroidal anti-inflammatory drugs in animal and human pain models. Semin Arthritis Rheum 1993; 23(3): 198–205
McCormack K. The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs 1994; 47Suppl. 5: 28–45
Okuyama S, Aihara S. The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal anti-inflammatory drugs. Jpn J Pharmacol 1984; 35: 95–103
Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 27: 270–81
Ward SJ. Pravadoline. A dual-mechanism aminoalkylindole analgesic. In: Lewis AJ, Furst DE, editors. 2nd ed. Nonsteroidal anti-inflammatory drugs. Mechanisms and clinical uses. New York: Marcel Dekker Inc. 1994; 297–316
McCormack K, Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. Drugs 1991; 41 (Pt 4): 533–47
McCormack K, Brune K. Toward defining the analgesic role of nonsteroidal anti-inflammatory drugs in the management of acute soft tissue injuries. Clin J Sport Med 1993; 3: 106–17
Brune K, Beck WS, Geisslinger G, et al. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 1991; 47: 257–61
Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544–7
Siegmund EA, Cadmus RA, Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol Med 1957; 95: 729–31
Urquhart E. Differentiation of NSAID efficacy through metaanalysis. Implications for the treatment of musculoskeletal pain [abstract no. 123]. Scand J Rheumatol 1994; Suppl. 98
Otterness IG, Bliven ML. Laboratory models for testing nonsteroidal antiinflammatory drugs. In: Lombardino JG, editor. Nonsteroidal antiinflammatory drugs. New York: John Wiley & Sons, 1985: 112–252
Cooper SA, Berrie R, Cohn P. Comparison of ketoprofen, ibuprofen, and placebo in a dental surgery pain model. Adv Ther 1988; 5: 43–53
Forbes JA, Beaver WT, Jones KF, et al. Analgesic efficacy of bromfenac, ibuprofen, and aspirin in postoperative oral surgery pain. Clin Pharmacol Ther 1992; 51: 343–52
Akarasereenont P, Mitchell JA, Thiemermann C, et al. Relative potency of nonsteroid anti-inflammatory drugs as inhibitors of cyclooxygenase-1 or cyclooxygenase-2. Br J Pharmacol 1994; 112 (Proceedings Supplement): 183P
Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflammed tissue. Arch Int Pharmacodyn Ther 1957; 111: 409–19
Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharm Exp Ther 1992; 263: 136–46
Reynolds IJ. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site. J Neurochem 1994; 62: 54–62
Bruni G, Runci FM, Fiaschi AI, et al. Inhibition of ornithine-decarboxylase produced by S(+) and R(−) ibuprofen in rats. Pharmacol Res 1990; 22: 97–102
Franzone JS, Cravanzola C, Reboani MC. Influence of non-steroidal anti-inflammatory compounds on the hepatic tryptophan pyrrolase activity in hypo- and hyperthyroid rats. Arch Int Pharmacodyn Ther 1980; 245: 156–65
Appendix: Animal Studies
Adams SS, McCullough KF, Nicholson JS. The pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and antipyretic agent. Arch Int Pharmacodyn Ther 1969; 178: 115–29
Adams SS, McCullough KF, Nicholson JS. Some biological properties of flurbiprofen, an anti-inflammatory, analgesic and antipyretic agent. Arzneimittel Forschung 1975; 25(11): 1786–91
Adams SS, Buckler JW. Ibuprofen and flurbiprofen. Clin Rheum Dis 1979; 5(2): 359–79
Aultz DE, Helsley GC, Hoffman D, et al. Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 1. 6, 11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acids. J Med Chem 1977; 20 (Pt 1): 66–70
Bartlett RR, Anagnosotpulos H, Zielinski T, et al. Effects of leflunomide on immune responses and models of inflammation. Springer Semin Immunopathol 1993; 14: 381–94
Beaver WT, Lasagna L. Zomepirac. J Clin Pharmacol 1980; 20(4) (Pt 2): 213–308
Boyle EA, Mangan FR. The histology and collagen content of cotton pellet and polyvinyl sponge-induced granulomas in normal and drug-treated rats. Br J Exp Pathol 1980; 61(4): 351–60
Boyle EA, Freeman PC, Mangan FR, et al. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent. J Pharm Pharmacol 1982; 34: 562–9
Capetola RJ, Shriver DA, Rosenthale ME. Activity of a new non-narcotic analgesic, suprofen, on pathologic-induced pain in the rat. Pharmacologist 1978; 20 (Pt 3): 270
Capetola RJ, Shriver DA, Rosenthale ME. Suprofen, a new peripheral analgesic. J Pharmacol Exp Ther 1980; 214(1): 216–23
Capetola RJ, Argentieri D, Weintraub HS, et al. Suprofen. In: Goldberg ME, editor. Pharmacological and biochemical properties of drug substances. American Pharmaceutical Association, 1981: 347–68
Carson JR, Wong S. 5-benzoyl-1-methylpyrrole-2-acetic acids as antiinflammatory agents. 2. The 4-methyl compounds. J Med Chem 1973; 16(2): 172–4
Castaner J, Hillier K. Amfenac. Drugs Future 1978; 3(5): 340–2
Cerelli MJ, Curtis DL, Dunn JP, et al. Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids. J Med Chem 1986; 29: 2347–51
Chau TT, Weichman BM, Sanda M. Pemedolac. In: Lewis AJ, Furst DE, editors. Nonsteroidal anti-inflammatory drugs. Mechanisms and clinical uses. 2nd ed. New York: Marcel-Dekker Inc, 1994: 285–95
Chi S-C, Jun HW. Anti-inflammatory activity of ketoprofen gel on carrageenan-induced paw edema in rats. J Pharm Sci 1990; 70(11): 974–7
Collier HOJ, Hammond AR, Horwood-Bennett S, et al. Rapid induction by acetylcholine, bradykinin and potassium of a nociceptive response in mice and its selective antagonism by aspirin. Nature 1964; 204: 1316–8
Collier HOJ, Dinneen LC, Johnson CA, et al. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 1968; 32: 295–310
Deraedt R, Benzoni J, Delevallée F. Pharmacological profile of tiaprofenic acid. Rheumatology 1982; 7: 78–87
Dubinsky B, Schupsky JJ. Mechanism of action of suprofen, a new peripheral analgesic, as demonstrated by its effects on several nociceptive mediators. Prostaglandins 1984; 28(2): 241–53
Dubinsky B, Gebre-Mariam S, Capetola RJ, et al. The antialgesic drugs: Human therapeutic correlates of their potency in laboratory animal models of hyperalgesia. Agents Actions 1987; 20 (1/2): 50–60
Faigle JW, Böttcher I, Godbillon J, et al. A new metabolite of diclofenac sodium in human plasma. Xenobiotica 1988; 18(10): 1191–7
Fowler PD. Voltarol: diclofenac sodium. Clin Rheum Dis 1979; 5(2): 427–64
Fujimura H, Tsurumi K, Hiramatsu Y, et al. Pharmacological studies of ketoprofen (19583 R.P.) (1) Anti-inflammatory, analgesic and antipyretic actions in oral administration. Folia Pharmacol Jpn 1974; 70: 543–69
Fujimura H, Tsurumi K, Hiramatsu Y, et al. 5-benzoyl-α-methyl-2-thiophene acetic acid (RU-15060). Pharmacometrics 1975; 9 (Pt 5): 715–25
Fujimura H, Tsurumi K, Nakayama T, et al. Effect of α-(p-thenolyphenyl)-propionic acid (TN-762) on acute inflammatory reactions and prostaglandin biosynthesis. Nippon Yakurigaku Zasshi 1981; 77 (Pt 3): 321–6
Fujimura H. Anti-inflammatory analgesic and antipyretic activities of α-(p-thenoylphenyl)-propionic acid (TN-762). Folia Pharmacol Jpn 1982; 79: 123–36
Fujiyoshi T, Iida H, Kuwashima M, et al. Pharmacological profile of alminoprofen among four writhing models of mice caused by kaolin, zymosan, acetylcholine and phenylquinone. J Pharmacobiodyn 1990; 13: 44–8
Garcia-Rafanell J, Forn J. Correlation between antiinflammatory activity and inhibition of prostaglandin biosynthesis by various non-steroidal antiinflammatory agents. Arzneimittel Forschung 1979; 29(4): 630–3
Gilman SC, Carlson RP, Chang J, et al. The antiinflammatory activity of the immunomodulator WY-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid). Agents Actions 1985; 17: 53–9
Glenn EM, Rohloff NA, Bowman BJ, et al. The pharmacology of 2-(2-fluoro-4-biphenylyl) propionic acid (flurbiprofen). A potent non-steroidal anti-inflammatory drug. Agents Actions 1973; 3(4): 210–6
Grau M, Guasch J, Montera JL, et al. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac. Arzneimittel Forschung 1991; 41 (Pt) (12) 1265–76
Guillet MC, Molinie B, Laduron P, et al. Effects of ketoprofen in adjuvant-induced arthritis measured in a new telemetric model test. Eur J Pharmacol 1990; 183(6): 2266–7
Hannah J, Ruyle WV, Jones V, et al. Novel analgesic-antiinflammatory salicylates. J Med Chem 1978; 21(11): 1093–100
Haubrich DR, Ward SJ, Baizman E, et al. Pharmacology of pravadoline: a new analgesic agent. J Pharmacol Exp Ther 1990; 255: 511–22
Hendershot LC, Forsaith J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J Pharmacol Exp Ther 1959; 125: 237–40
Higushi S, Otomo S. Antiedema effects of basic nonsteroidal anti-inflammatory drugs that are not inhibitors of prostaglandin biosynthesis. Folia Pharmacol Jpn 1985; 85: 343–6
Hirose K, Jyoyama Y, Kojima M, et al. Pharmacological properties of 2-[4-(2-thiazolyloxy)-phenyl]-propionic acid (480156-S), a new nonsteroidal anti-inflammatory agent. Arzneimittel Forschung 1984; 34 (Pt 1): 280–6
Hirschelmann R, Bekemeier II. Indirekte Wirkung nichtsteroidaler Antiphlogistika durch Hemmung der Phospholipase C? Pharmazie 1989; 44: H1
Humber LG. Etodolac: the chemistry, pharmacology, metabolic disposition, and clinical profile of a novel anti-inflammatory pyranocarboxylic acid. Med Res Rev 1987; 7 (Pt 1): 1–28
Inoue K, Fujisawa H, Sasaki Y, et al. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac. Arzneimittel Forschung 1991; 41: 228–35
Ito R, Suga T, Shimura M, et al. Pharmacological comparison of azapropazone and phenylbutazone, a new anti-inflammatory agent. Med Treat 1969; 2(4): 49–58
Jahn U, Adrian RW. Pharmakologische und toxikologische Prüfung des neuen Antiphlogisticums Azapropazon = 3-Dimethylamino-7-methyl-1-2-(2-propylmalonyl)-1, 2 dihydro-1, 2, 4-benzo-triazin. Arzneimittel Forschung 1969; 19: 36–52
Jahn U, Wagner-Jauregg T. Wirkungsvergleich säuer Antiphlogistika im Bradykinin, UB-Erythem und Rattenpfotenödem-Test. Arzneimittel Forschung 1974; 24: 494–9
Julou L, Guyonnet J-C, Ducrot R, et al. Étude des propriétés pharmacologiques d’un nouvel anti-inflammatoire, l’acide (benzoyl-3 phenyl)-2 propionique (19 583 RP). J Pharmacol (Paris) 1971; 2 (Pt 3): 259–86
Julou J, Guyonnet JC, Ducrot R, et al. Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties — outline of toxicological and pharmacokinetic data. Scand J Rheumatol 1976; 14 Suppl.: 33–44
Kaltenbronn JS, Scherrer RA, Short FW, et al. Structure-activity relationships in a series of anti-inflammatory N-arylanthranilic acids. Arzneimittel Forschung 1983; 33(4A): 621–7
Kimura I, Yoshida M, Sato M. Combined effects of emorfazone with non-steroidal acidic anti-inflammatory drugs — Pharmacological effects and toxicity. Jpn J Pharmacol Ther 1985; 13 (Pt 5): 267–77
Krupp PJ, Manassé-Gdynia R, Sallmann A, et al. Sodium (o-((2,6-dichlorophenyl)-amino)-phenyl)-acetate (GP45 840), a new non-steroidal anti-inflammatory agent. Experientia 1973; 29(4): 450–2
Krupp P, Exer B, Menassé R, et al. New aspects of inflammation prevention by means of non-steroid antiphlogistics: the effect of Voltaren. Schweiz Med Wochenschr 1975; 105(20): 646–52
Lewis AJ, Carlson RP, Chang J, et al. The pharmacological profile of oxaprozin, an antiinflammatory and analgesic agent with low gastrointestinal toxicity. Curr Ther Res 1983; 34(5): 777–94
Lombardino JG, Otterness IG, Wiseman EH. Acidic antiinflammatory agents — correlations of some physical, pharmacological and clinical data. Arzneimittel Forschung 1975; 25(10): 1629–35
Loux JJ, Smith S, Salem H. Comparative analgesic testing of various compounds in mice using writhing techniques. Arzneimittel Forschung 1978; 28: 1644–7
Luttinger D, Koonz D, Chippari S. Phenyl-p-quinone writhing in mice: can it predict analgesic efficacy? Pharmacologist 1988; 30: A155
Mackenzie AR. Pharmacological properties of IX 207-887. In: Lewis AJ, Furst DE, editors. Nonsteroidal anti-inflammatory drugs. Mechanisms and clinical uses. 2nd ed. New York: Marcel-Dekker Inc, 1994: 391–410
Maeda M, Tanaka Y, Suzuki T, et al. Pharmacological studies on carprofen, a new non-steroidal anti-inflammatory drug, in animals. Nippon Yakurigaku Zasshi 1977; 73(7): 757–77
Maier R, Manassé R, Riesterer L, et al. The pharmacology of diclofenac sodium (Voltarol). Rheumatol Rehabil 1979; Suppl. 2: 11–21
Martel RR, Klicius J. Anti-inflammatory and analgesic properties of etodolac acid in rats. Can J Physiol Pharmacol 1976; 54(3): 245–8
Maruyama Y, Terasawa M, Anami K, et al. Pharmacological studies of 2-(5H-(1)benzopyrano(2,3-b)pyridin-7-yl) propionic acid (Y-8004). Anti-inflammatory, analgesic and antipyretic actions. Nippon Yakurigaku Zasshi 1975; 71(8): 857–73
Maruyama Y, Anami K, Terasawa M, et al. Anti-inflammatory activity of an imidazopyridine derivative (miroprofen). Arzneimittel Forschung 1981; 31(7): 1111–8
Masumoto S, Masuda C. Mechanism of anti-inflammatory action of 2-(2-fluoro-4-biphenylyl) propionic acid (flurbiprofen). Nippon Yakurigaku Zasshi 1976; 72(6): 753–62
McCord JM, Stokes SH, Wong K. In: Weissman G, Samuelsson B, Paoletti R, editors. Advances in inflammation research. New York: Raven Press, 1979; 1: 273–80
McGuire JL, Niemegeers CJE, Shriver DA, et al. Antinociceptive properties of suprofen, a new analgesic agent. Fed Proc 1978; 37(3): 769
Melarange R, Gentry C, O’Connell C, et al. Anti-inflammatory efficacy and gastrointestinal irritancy: comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenac. Agents Actions 1991; 32 Suppl: 33–7
Menasse R, Hedwall PR, Kraetz J, et al. Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol 1978; 22 Suppl.: 5–16
Metzner J, Paintz M. Analgestische, antiphlogistische und toxische Wirkungen von 3-substituierten Benzo-1,2,4-triazinen. Pharmazie 1981; 36(10): 714
Milne GM, Twomey TM. The analgetic properties of piroxicam in animals and correlation with experimentally determined plasma levels. Agents Actions 1980; 10(1) (Pt 2): 31–7
Moreno JJ, Calvo L, Fernandez F, et al. Biological activity of ketoprofen and its optical isomers [abstract]. XIth International Congress of Pharmacology; 1990 July 6; Amsterdam, The Netherlands. Eur J Pharmacol 1990; 183 (Pt 6); 2263 Ab:PFT170
Mörsdorf K, Anspach K. Zur Wirkungspotenz verschiedener Antiphlogistika bei der ‘Carrageenin-Entzündung’ im Vergleich zu anderen Entzündungsmodellen. Arch Int Pharmacodyn Ther 1971; 192: 111–27
Mörsdorf K, Wolf G. Vergleichende Untersuchungen zur Wirkungspotenz neuerer Antiphlogistika. Arzneimittel Forschung 1972; 22(12): 2105–10
Muchowski JM, Unger SH, Ackrell J, et al. Synthesis and antiinflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrolo[1-2a-]pyrrole-1-carboxylic acids and related compounds. J Med Chem 1985; 28: 1037–49
Nakamura H, Yokoyama Y, Motoyoshi S, et al. Anti-inflammatory activity of a non-steroidal anti-inflammatory agent, zomepirac sodium, in experimental animals. Nippon Yakurigaku Zasshi 1982; 79(6): 509–27
Nasa Y, Yano K, Shinozawa S, et al. Pharmacological profiles of Aneol suppository (ketoprofen rectal capsule). Jpn Pharmacol Ther 1986; 14 (Pt 4): 287–97
Neuman RG, Wilson BD, Barkley M, et al. Inhibition of prostaglandin biosynthesis by etodolac. 1. Selective activities in arthritis. Agents Actions 1987; 2 (Pt 1–2): 160–5
Niemegeers CJE, Janssen PAJ. Suprofen, a potent antagonist of sodium urate crystal-induced arthritis in dogs. Arzneimittel Forschung 1975; 25(10): 1512–5
Niemegeers CJE, Verbruggen FJ, Janssen PAJ. Effect of various drugs on carrageenin-induced oedema in the rat hind paw. J Pharm Pharmacol 1964; 16(2): 810–6
Niemegeers CJE, Van Bruggen JAA, Janssen PAJ. Suprofen, a potent antagonist of acetic acid-induced writhing in rats. Arzneimittel Forschung 1975; 25(10): 1505–9
Nikolov R, Stefanova D, Nikolova M, et al. Feloran (diclofenac sodium). Study on its analgesic effect. Medico-Biologic Information (Bg) 1983: 1: 3–5
Noguchi Y, Ishiko J, Ohtsuki I. Comparative pharmacological profiles of piroxicam, indomethacin, phenylbutazone, diclofenac, ibuprofen, and mefenamic acid. RSM Int Cong Symp Series 1985; 67: 61–7
Otterness IG, Wiseman EH, Gans DJ. A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritis. Agents Actions 1979; 9(2): 177–83
Otterness IG, Gans DJ. Nonsteroidal anti-inflammatory drugs: An analysis of the relationship between laboratory animal and clinical doses, including species scaling. J Pharm Sci 1988; 77(9): 790–5
Pong SF, Demuth SM, Kinney CM, et al. Prediction of human analgesic dosages of nonsteroidal anti-inflammatory drugs (NSAIDs) from analgesic ED50 values in mice. Arch Int Pharmacodyn Ther 1985; 273: 212–20
Pruss TP, Gardocki JF, Taylor RJ, et al. Evaluation of the analgesic properties of zomepirac. J Clin Pharmacol 1980; 20: 216–22
Randall LO, Baruth H. Analgesic and anti-inflammatory activity of 6-chloro-alpha-methyl-carbazole-2-acetic acid (C-5720). Arch Int Pharmacodyn Ther 1976; 220(1): 94–114
Regan BA, Hanifin JW, Landes MJ, et al. Anti-inflammatory and analgesic profile of amidines of 3-amino-1,2,4-benzotriazine and 3-amino-1,2,4-benzotriazine-1-oxide. J Pharm Sci 1980; 69(7): 789–93
Reiter MJ, Schwartzmiller DH, Swingle KF, et al. Comparison of anti-inflammatory compounds in the carrageenan induced paw edema model and the reversed passive arthus model utilizing the same animal. Life Sci 1985; 36: 1339–46
Rooks WH, Tomolonis AJ, Maloney PJ, et al. The anti-inflammatory and analgesic profile of 6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-acetic acid (Tiopinac). Agents Actions 1980; 10/3: 266–73
Rooks WH, Tomolonis AJ, Maloney PJ, et al. The analgesic and anti-inflammatory profile of (±)-5-benzoyl-1,2-dihydro-3H-pyrrolo [1,2a]pyrrole-1-carboxylic acid (RS-37619). Agents Actions 1982; 12: 684–90
Rooks WH, Maloney JP, Shott LD, et al. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp Clin Res 1985; 11(8): 479–92
Roszkowski AP, Rooks WH, Tomolonis AJ, et al. Anti-inflammatory and analgetic properties of d-2-(6′-methoxy-2′-naphthyl)-propionic acid (naproxen). J Pharmacol Exp Ther 1971; 179(1): 114–23
Sancilio LF, Reese DL, Cheung S, et al. AHR-5850: a potent anti-inflammatory compound. Agents Actions 1977; 7(1): 133–44
Sancilio LF, Nolan JC, Wagner LE, et al. The analgesic and anti-inflammatory activity and pharmacologic properties of bromfenac. Arzneimittel Forschung 1987; 37(5): 513–9
Shirota H, Chiba K, Goto M, et al. Antiinflammatory properties of E5090, a novel orally active inhibitor of IL-1 generation. Agents Actions 1991; 20 Suppl.: 219–23
Shvarts GIA, Siubaev RD. Sootnoshenie antieksudativnogo, anal’geticheskogo i zharoponizhaiushchego komponentov v deistvii nesteroidnykh protivovospalitel’nykh preparatov. Farmakol Toksikol 1982; 45(1): 46–9
Sloboda AE, Osterberg AC. The pharmacology of fenbufen, 3-(4-biphenylylcarbonyl) propionic acid, and 4-biphenylacetic acid, interesting anti-inflammatory-analgesic agents. Inflammation 1976; 1(4): 415–38
Sofia RD, Danielsen L, Vassar HB. Comparative effects of anti-arthritic and other pharmacological agents in the 18-hour arthritis and carrageenan edema tests in rats. Pharm Res Commun 1979; 11(2): 179–93
Stewart PE. A comprehensive approach to the development of a new potent and versatile analgesic: zomepirac sodium. Eur J Rheumatol Inflamm 1981; 4(4): 462–8
Strub K, Aeppli L, Mueller RK. Pharmacological properties of carprofen. Eur J Rheumatol Inflamm 1982; 5(4): 478–87
Sunkel C, Cillero F, Armijo F, et al. Synthesis and pharmacological properties of eterylate, a new derivative of acetylsalicylic acid. Arzneimittel Forschung 1978; 28(10): 1692–4
Swingle KF, Grant TJ, Kvam DC. Quantal responses in the Randall-Selitto assay (35615). Proc Soc Exper Biol Med 1971; 137(2): 536–8
Takesue El, Schaefer W, Jukniewicz E. Modification of the Randall-Selitto analgesic apparatus. J Pharm Pharmacol 1969; 21(11): 788–9
Tarayre JP, Lauressergues H. Advantages of a combination of proteolytic enzymes, flavanoids and ascorbic acid in comparison with non-steroid anti-inflammatory agents. Arzneimittel Forschung 1977; 27(6): 1144–9
Tolman EL, Capetola RJ, McGuire JL, et al. Suprofen: Pharmacological, biochemical and clinical activities of a new, non-narcotic peripheral analgesic. In: Huskisson EC, editor. Anti-rheumatic drugs. Clinical pharmacology and therapeutics series. Vol. 3; Praeger Publishers, 1983: 439–51
Ueno K, Kubo S, Tagawa H, et al. 6,11-dihydro-11-oxodibenz [b.e] oxepinacetic acids with potent antiinflammatory activity. J Med Chem 1976; 19(7): 941–6
Van Daele PGH, Boey JM, Sipido VK, et al. Synthesis of α-methyl-4-(2-thienylcarbonyl)benzeneacetic acid, suprofen, and derivatives. Arzneimittel Forschung 1975; 25(10): 1495–501
Wagner-Jauregg T, Jahn U, Bürlimann W. Fibrinolytische Antirheumatika. Vergleich von Substanzen der Flufenamsäure-Reihe mit Trifluormethyl-Analogen des Azapropazons. Arzneimittel Forschung 1973; 23(7): 911–3
Walford GL, Jones H, Shen TY. Aza analogs of 5-(p-fluorophenyl) salicylic acid. J Med Chem 1971; 14: 339–44
Welstead WJ Jr, Moran HW, Stauffer HF, et al. Antiinflammatory agents. 1. Synthesis and antiinflammatory activity of 2-amino-3-benzoylphenylacetic acid. J Med Chem 1979; 22 (Pt 9): 1074–9
Wiesenberg-Boettcher J, Pfeilschifter J, Schweizer A, et al. Pharmacological properties of five diclofenac metabolites identified in human plasma. Agents Actions 1991; 34(1/2) 135–7
Winder CV, Wax J, Scotti RA, et al. Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-XYLYL) anthranilic acid (mefenamic acid). J Pharmacol Exp Ther 1962; 138(3): 405–13
Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544–7
Winter CA. Anti-inflammatory testing methods: Comparative evaluation of indomethacin and other agents. Int Congress Ser 1966; 82: 190–2
Winter CA, Kling PJ, Tocco DJ, et al. Analgesic activity of diflunisal [MK-647; 5-(2,4-difluorophenyl) salicylic acid] in rats with hyperalgesia induced by Freund’s adjuvant. J Pharmacol Exp Ther 1979; 211(3): 678–85
Wiseman EH, Chang YH, Lombardino JG. Piroxicam, a novel anti-inflammatory agent. Arzneimittel Forschung 1976; 26(7): 1300–3
Wong S, Gardocki JF, Pruss TP. Pharmacologic evaluation of tolectin (tolmetin, mcn-2559) and mcn-2891, two anti-inflammatory agents. J Pharmacol Exp Ther 1973; 185(1): 127–38
Yamaguchi E, et al. The inhibitory activities of 480156-S and its related compounds on prostaglandin synthetase. Nippon Yakurigaku Zasshi 1987; 90(5): 295–302
Yoshioka T, Kitagawa M, Oki M, et al. Nonsteroidal antiinflammatory agents. 2. Derivatives/analogues of dibenz[b,e]oxepin-3-acetic acid. J Med Chem 1978; 21 (Pt 7): 633–9
Young JM, Yee JR. Ketorolac. In: Lewis AJ, Furst DE, editors. Nonsteroidal anti-inflammatory drugs. Mechanisms and clinical uses. 2nd ed. New York: Marcel-Dekker Inc, 1994: 247–66
Zuccari G, Luzzani F, Fiorcari P, et al. Biological activities of CO/1828, a novel topical antiinflammatory agent [abstract]. XIth International Congress of Pharmacology; 1990 July 6; Amsterdam, The Netherlands. Eur J Pharmacol 1990; 183 (Pt 6); 2264 Ab:PFT171
Clinical Studies
Cooper SA, Needle SE, Kruger GO. Comparative analgesic potency of aspirin and ibuprofen. J Oral Surg 1977; 35: 898–903
Cooper SA, Engel J, Ladov M, et al. Analgesic efficacy of an ibuprofen-codeine combination. Pharmacotherapy 1982; 2: 162–7
Cooper SA, Gelb SB, Maggio Cavaliere MB, et al. An analgesic relative potency assay comparing ketoprofen and aspirin in postoperative dental pain. Adv Ther 1984; 6: 410–8
Cooper SA, Wagenberg B, Zissu J, et al. The analgesic efficacy of suprofen in periodontal and oral surgical pain. Pharmacotherapy 1986; 6: 267–76
Cooper SA, Berrie R, Cohn P. Comparison of ketoprofen, ibuprofen, and placebo in a dental surgery pain model. Adv Ther 1988; 5: 43–53
Cooper SA, Mardirossian G, Milles M. Analgesic relative potency assay comparing flurbiprofen 50, 100, and 150mg, aspirin 600mg, and placebo in postsurgical dental pain. Clin J Pain 1988; 4: 175–81
Dionne RA, Cooper SA. Evaluation of preoperative ibuprofen for postoperative pain after removal of third molars. Oral Surg 1978; 45: 851–6
Fliedner L, Levsky M, Kechejian H, et al. Analgesia with etodolac in oral postsurgical pain. Curr Ther Res 1984; 36: 33–45
Forbes JA, Calderazzo JP, Bowser MW, et al. A 12-hour evaluation of the analgesic efficacy of diflunisal, aspirin, and placebo in postoperative dental pain. J Clin Pharmacol 1982; 22: 89–96
Forbes JA, Butterworth GA, Burchfield WH, et al. A 12-hour evaluation of the analgesic efficacy of diflunisal, zomepirac sodium, aspirin, and placebo in postoperative oral surgery pain. Pharmacotherapy 1983, 3 Suppl.: 38S–46S
Forbes JA, Barkaszi BA, Ragland RN, et al. Analgesic effect of fendosal, ibuprofen and aspirin in postoperative oral surgery pain. Pharmacotherapy 1984; 4: 385–91
Forbes JA, Keller CK, Smith JW, et al. Analgesic effect of naproxen sodium, codeine, a naproxen-codeine combination and aspirin on the postoperative pain of oral surgery. Pharmacotherapy 1986; 6: 211–8
Forbes JA, Yorio CC, Selinger LR, et al. An evaluation of flurbiprofen, aspirin, and placebo in postoperative oral surgery pain. Pharmacotherapy 1989; 9: 66–73
Forbes JA, Butterworth GA, Burchfield WH, et al. Evaluation of ketorolac, aspirin, and an acetaminophen-codeine combination in postoperative oral surgery pain. Pharmacotherapy 1990; 10 Suppl.: 77S–93S
Forbes JA, Kehrn CJ, Grodin CD, et al. Evaluation of ketorolac, ibuprofen, acetaminophen, and an acetaminophen-codeine combination in postoperative oral surgery pain. Pharmacotherapy 1990; 10 Suppl.: 94S–105S
Forbes JA, Edquist IA, Smith FG, et al. Evaluation of bromfenac, aspirin, and ibuprofen in postoperative and surgery pain. Pharmacotherapy 1991; 11: 64–70
Gaston GW, Mallow RD, Frank JE. The efficacy of etodolac for patients with pain following oral surgery. J Oral Maxillofac Surg 1984; 42: 362–6
Guedes MS, Coutinho A. Atividade analgésica do fenbufen em odontalgia: Comparação com aspirina, codeína, propoxifeno e placebo. Folha Médica 1975; 71: 593–6
Henrikson P-Å, Thilander H, Wåhlander LÅ. Absorption and effect of diclofenac sodium after surgical removal of a lower wisdom tooth. Curr Ther Res 1982; 31: 20–6
Hutton CE. The effectiveness of 100 and 200 mg etodolac (ultradol), aspirin, and placebo in patients with pain following oral surgery. Oral Surg Oral Med Oral Pathol 1983; 56: 575–80
Jain AK, Hunley CC, Kuebel J, et al. Analgesic efficacy of amfenac, aspirin and placebo after extraction of impacted teeth. Pharmacotherapy 1986; 6: 236–40
Mardirossian G, Cooper SA. Comparison of the analgesic efficacy of flurbiprofen and aspirin for postsurgical dental pain. J Oral Maxillofac Surg 1985; 43: 106–9
Mehlisch D, Frakes L, Cavaliere MB, et al. Double-blind parallel comparison of single oral doses of ketoprofen, codeine, and placebo in patients with moderate to severe dental pain. J Clin Pharmacol 1984; 24: 486–92
Melzack R, Bentley KC, Jeans ME. Piroxicam versus acetaminophen and placebo for the relief of postoperative dental pain. Curr Ther Res 1985; 37: 1134–40
Rowe NH, Cudmore CL, Turner JL. Control of pain by mefenamic acid following removal of impacted molar. Oral Surg 1981; 51: 575–80
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCormack, K., Urquhart, E. Correlation between Nonsteroidal Anti-Inflammatory Drug Efficacy in a Clinical Pain Model and the Dissociation of their Anti-Inflammatory and Analgesic Properties in Animal Models. Clin. Drug Invest. 9, 88–97 (1995). https://doi.org/10.2165/00044011-199509020-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-199509020-00005